These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37574809)
1. Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea. Joe S; Kim J; Lee JY; Jeon J; Byeon I; Han SW; Ryoo SB; Park KJ; Song SH; Cho S; Shim H; Bao Khanh Chu H; Kang J; Lee HS; Kim D; Kim YJ; Kim TY; Kim SY BMB Rep; 2023 Oct; 56(10):563-568. PubMed ID: 37574809 [TBL] [Abstract][Full Text] [Related]
2. Deciphering the DNA methylation landscape of colorectal cancer in a Korean cohort. Lim SB; Joe S; Kim HJ; Lee JL; Park IJ; Yoon YS; Kim CW; Kim JH; Kim S; Lee JY; Shim H; Bao Khanh Chu H; Cho S; Kang J; Kim SC; Lee HS; Kim YJ; Kim SY; Yu CS BMB Rep; 2023 Oct; 56(10):569-574. PubMed ID: 37605616 [TBL] [Abstract][Full Text] [Related]
3. Exploring the DNA methylome of Korean patients with colorectal cancer consolidates the clinical implications of cancer-associated methylation markers. Lee S; Lee KY; Park JH; Kim DW; Oh HK; Oh ST; Jeon J; Lee D; Joe S; Chu HBK; Kang J; Lee JY; Cho S; Shim H; Kim SC; Lee HS; Kim YJ; Yang JO; Lee J; Kang SB BMB Rep; 2024 Mar; 57(3):161-166. PubMed ID: 37964634 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive profiling of DNA methylation in Korean patients with colorectal cancer. Shim H; Jang K; Bang YH; Chu HBK; Kang J; Lee JY; Cho S; Lee HS; Jeon J; Hwang T; Joe S; Lim J; Choi JH; Joo EH; Park K; Moon JH; Han KY; Hong Y; Lee WY; Kim HC; Yun SH; Cho YB; Park YA; Huh JW; Shin JK; Pyo DH; Hong H; Lee HO; Park WY; Yang JO; Kim YJ BMB Rep; 2024 Feb; 57(2):110-115. PubMed ID: 37605617 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer. McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398 [TBL] [Abstract][Full Text] [Related]
6. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. Ang PW; Loh M; Liem N; Lim PL; Grieu F; Vaithilingam A; Platell C; Yong WP; Iacopetta B; Soong R BMC Cancer; 2010 May; 10():227. PubMed ID: 20492682 [TBL] [Abstract][Full Text] [Related]
8. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Hinoue T; Weisenberger DJ; Lange CP; Shen H; Byun HM; Van Den Berg D; Malik S; Pan F; Noushmehr H; van Dijk CM; Tollenaar RA; Laird PW Genome Res; 2012 Feb; 22(2):271-82. PubMed ID: 21659424 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis. Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS Mod Pathol; 2006 Aug; 19(8):1083-90. PubMed ID: 16699497 [TBL] [Abstract][Full Text] [Related]
10. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer. Yanokura M; Banno K; Adachi M; Aoki D; Abe K Int J Oncol; 2017 Jun; 50(6):1934-1946. PubMed ID: 28440489 [TBL] [Abstract][Full Text] [Related]
12. Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status. Kim JH; Rhee YY; Bae JM; Kwon HJ; Cho NY; Kim MJ; Kang GH Mod Pathol; 2013 Jul; 26(7):1013-22. PubMed ID: 23370766 [TBL] [Abstract][Full Text] [Related]
13. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers. An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317 [TBL] [Abstract][Full Text] [Related]
14. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers? Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. Hinoue T; Weisenberger DJ; Pan F; Campan M; Kim M; Young J; Whitehall VL; Leggett BA; Laird PW PLoS One; 2009 Dec; 4(12):e8357. PubMed ID: 20027224 [TBL] [Abstract][Full Text] [Related]
16. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci. Kawasaki T; Ohnishi M; Nosho K; Suemoto Y; Kirkner GJ; Meyerhardt JA; Fuchs CS; Ogino S Mod Pathol; 2008 Mar; 21(3):245-55. PubMed ID: 18204436 [TBL] [Abstract][Full Text] [Related]
18. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype. Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype. Bae JM; Kim JH; Kang GH Histol Histopathol; 2013 May; 28(5):585-95. PubMed ID: 23341177 [TBL] [Abstract][Full Text] [Related]
20. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high. Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]